Treatment with angiotensin II in COVID-19 patients may not be beneficial

Benzer Materyaller

• Treatment with angiotensin II in COVID-19 patients may not be beneficial
  Yazar:: Susanne Rysz, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-09-01)
• COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
  Yazar:: Rysz, Susanne, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Continuous renal replacement therapy in intensive care patients with COVID-19; survival and renal recovery
  Yazar:: Eriksson, Karin E., ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Characteristics and outcomes of patients with COVID‐19 admitted to ICU in a tertiary hospital in Stockholm, Sweden
  Yazar:: Larsson, Emma, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• The Use of Levosimendan after Out-of-Hospital Cardiac Arrest and Its Association with Outcome—An Observational Study
  Yazar:: Susanne Rysz, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-05-01)